Prevalence of microorganism and emergence of bacterial resistance in ICU of Bangabandhu Sheikh Mujib Medical University of Bangladesh

Mondal, Montosh Kumar; Roy, Beauty Rani; Yeasmeen, Sabina; Haque, Faizul; Huda, AK Qumrul; Banik, Debabrata

doi:10.3329/jbsa.v26i1.19811

Cited by 2 publications

(3 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic helps to illustrate the possible long-term effects of AMR, which is less severe but not less critical since their measurements and outcomes are comparable. Understanding how COVID-19 influences AMR trends and what to assume if they remain the same or increase in AMR will help us plan the next steps in addressing AMR [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance

et al. 2021

View full text Add to dashboard Cite

Antimicrobial resistance (AMR) is a global health issue that plays a significant role in morbidity and mortality, especially in immunocompromised patients. It also becomes a serious threat to the successful treatment of many bacterial infections. The widespread and irrelevant use of antibiotics in hospitals and local clinics is the leading cause of AMR. Under this scenario, the study was conducted in a tertiary care hospital in Lahore, Pakistan, from 2 August 2021 to 31 October 2021 to discover the prevalence of bacterial infections and AMR rates in COVID-19 patients admitted in surgical intensive care units (SICUs). Clinical samples were collected from the patients and we proceeded to identify bacterial isolates, followed by antibiotic susceptibility testing (AST) using the Kirby Bauer disk diffusion method and minimum inhibitory concentration (MIC). The data of other comorbidities were also collected from the patient’s medical record. The current study showed that the most common pathogens were E. coli (32%) and Klebsiella pneumoniae (17%). Most E. coli were resistant to ciprofloxacin (16.8%) and ampicillin (19.8%). Klebsiella pneumoniae were more resistant to ampicillin (13.3%) and amoxycillin (12.0%). The most common comorbidity was chronic kidney disease (CKD) and urinary tract infections (UTIs). Around 17 different types of antibiotic, the carbapenem, fluoroquinolones, aminoglycoside, and quinolones, were highly prevalent in ICU patients. The current study provides valuable data on the clinical implication of antibiotics consumed by COVID-19 patients in SICUs and the AMR rates, especially with different comorbidities.

show abstract

Section: Introductionmentioning

confidence: 99%

“…COVID-19 infections have far exceeded bacterial co-infection and mortality rates compared to other common respiratory viral infections [ 2 ]. The co-infection of SARS-CoV-2 with other microbes, mainly bacteria and fungus, is a determining factor in COVID-19 development, making diagnosis, treatment, and prognosis more complicated.…”

Section: Introductionmentioning

confidence: 99%

The Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Again, most of the studies done in Bangladesh, concentrate on a single disease, pathogen, or specimen. [37][38][39][40][41][42][43][44][45][46][47][48][49][50][51] But, a single organism can cause different types of infection, at different sites and can cause different diseases. For example, E. coli can cause gastroenteritis, sepsis, UTI, even meningitis.…”

Section: Introductionmentioning

confidence: 99%

Prevalent Bacteria and Their Sensitivity and Resistance Pattern to Antibiotics: A Study in Dhaka Medical College Hospital

Hossain

Naher²,

Hasan

et al. 2017

J Dhaka Med Coll

View full text Add to dashboard Cite

amikacin, moxifloxacin, imipenem, meropenem, piperacillin+tazobactum combination, vancomycin, doxycycline, tetracycline, tigecycline, nitrofurantoin, azactum, linezolid and 100% resistant to cefixime. Enterobacter was 100% sensitive to penicillin, amikacin, gentamicin, netilmicin, doxycycline, tetracycline, tigecycline and 100% resistant to cefixime, ceftazidime, ceftriaxone, cefepime, cotrimoxazole, levofloxacin, vancomycin. E. coli was 100% sensitive to imipenem, meropenem, vancomycin, tigecycline and 100% resistant to mecillinam, aztreonam. Klebsiella was 100% sensitive to flucloxacillin, colistin, vancomycin, tigecycline, linezolid and 100% resistant to nalidixic acid. Proteus was 100% sensitive to cephradine,

show abstract

Prevalence of microorganism and emergence of bacterial resistance in ICU of Bangabandhu Sheikh Mujib Medical University of Bangladesh

Abstract: Background Antibiotic resistant bacterial nosocomial infections are a leading problem in intensive care units (ICU). Objective 12(20.33%) in 2010, 2(20%) in 2011 and 13(25%) in 2012. only collistin sensitive organism identified was 28(23.14%).

Cited by 2 publications

References 27 publications

The Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance

The Usage of Antibiotics by COVID-19 Patients with Comorbidities: The Risk of Increased Antimicrobial Resistance

Prevalent Bacteria and Their Sensitivity and Resistance Pattern to Antibiotics: A Study in Dhaka Medical College Hospital

Contact Info

Product

Resources

About